WASHINGTON, DC – SEPTEMBER 21, 2010 – Three-year data from the prospective, randomized LEADERS trial demonstrate the equivalence of a biolimus A9-eluting stent with a biodegradable polymer vs. a sirolimus-eluting stent with a durable polymer. The results will be presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
The study is to be presented by Patrick W. Serruys, MD, PhD, Professor of Interventional Cardiology at the Thoraxcenter, Erasmus Medical Center (Rotterdam, Netherlands.)